News

Biotronik Home Monitoring ECOST Clinical Trial ICDs

Biotronik announced that the European Heart Journal has published the clinical results of the ECOST trial (...

Miracor Medical Systems PICSO Clinical Trial Study

Miracor Medical Systems GmbH announced that its PICSO system was used for the first time under CE mark in the United Kingdom to treat a patient with a large acute heart attack, or ST-segment...

CathPCI Registry Interventional Cardiology Data Cath Lab JACC

A report from the CathPCI Registry, a data registry that includes information from 85 percent of the heart catheterization laboratories in the United States, is providing a vivid snapshot of the...

SCAI Ad Hoc PCI Stenting Cath Lab Clinical Trial

When tests reveal that a patient’s heart artery is blocked and blood flow to the heart is restricted, should the doctor fix it with a stent or stop the test and discuss treatment options with the...

The first patient has been implanted with the Boston Scientific Corporation next generation Ingevity pacing leads in a clinical trial designed to establish the safety, performance and...

Among deployed U.S. service members who died of combat or unintentional injuries between 2001-2011 and underwent autopsies, the prevalence of coronary atherosclerosis was 8.5 percent, with factors...

December 28, 2012 — Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects...

December 27, 2012 — Cardiosonic Inc., a private developer of technology in the field of renal denervation for the treatment of hypertension, announced it has closed on the first $6.1 million of a...

December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United States. The BIOHELIX–I trial is set to evaluate the safety and...

December 26, 2012 — St. Jude Medical Inc. announced the first patient enrollment in its ILUMIEN I clinical study. The observational study is designed to show the optimal way optical coherence...

RealView's 3-D holographic projection of a heart

The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting brings many cutting-edge technologies to the forefront during its five days of clinical sessions. This is my editor’s choice of...

Despite earlier signs that a less-invasive surgery is safer and better than “open” operations to repair potentially lethal abdominal aortic aneurysms, a clinical study led by a Johns Hopkins...

December 20, 2012 — BlipCare has presented the world's first Wi-Fi blood pressure monitor on international crowd funding site Indiegogo.

December 19, 2012 — The first patient has been enrolled in the Boston Scientific EVOLVE II clinical trial, which is designed to further assess the safety and effectiveness of the Synergy ...

New streamlined guidelines will help healthcare providers better treat patients with the most severe type of heart attacks, according to an American Heart Association/American College of...

BioControl Medical European Journal of Heart Failure Vagus Nerve Stimulation

BioControl Medical has announced that the pilot clinical study of its CardioFit vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart...

Hospitalized children who suffer cardiac arrest are nearly three times more likely to survive than they were about a decade ago, and no more likely to suffer brain impairment, according to new...

BioControl Medica Clinical Study CardioFit Vagus European Journal of Heart Failu

BioControl Medical has announced that the pilot clinical study of its CardioFit vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart...

For functional mitral valve regurgitation, the results of open repair are poor, but the next generation of transcatheter heart valve repair technologies in development may offer new hope for these...

Congenital Heart Disease Certification American Board of Medical Specialties

More than a million adult congenital heart disease patients in the United States will soon be able to choose a specialist who has demonstrated the unique knowledge and skills their care requires...